Craig Thompson

Directeur/Membre du Conseil chez CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Fortune : 2 M $ au 31/08/2026

Profil

Dr. Craig B. Thompson, MD, is an Independent Director at Charles River Laboratories International, Inc., an Independent Director at Regeneron Pharmaceuticals, Inc., a Member at American Academy of Arts & Sciences, a Member at American Association of Physicists In Medicine, a Member at American Society for Clinical Investigation, a Member at Association of American Physicians, a Member at National Academy of Medicine (United States) and a Member at National Academy of Sciences.
He is on the Board of Directors at Charles River Laboratories International, Inc., Regeneron Pharmaceuticals, Inc., Memorial Sloan Kettering Cancer Center, American Association for Cancer Research, City of Hope Comprehensive Cancer Center, New York Genome Center, Ohio State University Comprehensive Cancer Center, The University of Texas M.D.
Anderson Cancer Center and The Economic Club of New York.
Dr. Thompson was previously employed as an Independent Director by Merck & Co., Inc., a Co-Founder by Agios Pharmaceuticals, Inc., an Associate Vice President-Cancer Services by The University of Pennsylvania Health System, a Professor by University of Pennsylvania, a Professor by Perelman School of Medicine, a Professor by University of Michigan, a Professor by Uniformed Services University of the Health Sciences, a President, Chief Executive Officer & Director by Memorial Sloan-Kettering Cancer Center (Investment Management), and a President & Chief Executive Officer by The Society of Memorial Sloan-Kettering Cancer Center.
He also served on the board at Charles River Laboratories, Inc., Schering-Plough Corp.
USA, Abramson Cancer Center and Howard Hughes Medical Institute, Inc. He received his undergraduate degree from Dartmouth College and a doctorate degree from the University of Pennsylvania.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 0,01 %	08/05/2026	3 851 ( 0,01 % )	1 M $	31/08/2026
REGENERON PHARMACEUTICALS, INC. 0 %	14/04/2026	688 ( 0 % )	549 767 $	31/08/2026

Postes actifs de Craig Thompson

Sociétés	Poste	Début
REGENERON PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	03/10/2022
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Directeur/Membre du Conseil	05/12/2022
City of Hope Comprehensive Cancer Center	Directeur/Membre du Conseil	-
Ohio State University Comprehensive Cancer Center	Directeur/Membre du Conseil	-
The University of Texas M.D. Anderson Cancer Center	Directeur/Membre du Conseil	-
New York Genome Center	Directeur/Membre du Conseil	-
The Economic Club of New York	Directeur/Membre du Conseil	-
American Association of Physicists In Medicine	Corporate Officer/Principal	-
American Society for Clinical Investigation	Corporate Officer/Principal	-
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-

Anciens postes connus de Craig Thompson

Sociétés	Poste	Fin
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░ ░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	-
░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░